Company Overview - Autonomix Medical, Inc. is a medical device company focused on innovative technologies for diagnosing and treating diseases of the nervous system [3] - The company is developing a first-in-class platform system technology that includes a catheter-based microchip sensing array, which may detect and differentiate neural signals with approximately 3,000 times greater sensitivity than current technologies [3] - The initial focus of the technology is on treating pain, particularly in pancreatic cancer, which is known for causing debilitating pain and lacks reliable treatment options [4] Stock Option Grant - The Compensation Committee of Autonomix's Board of Directors approved an inducement stock option grant on March 17, 2025, for a new non-executive employee to purchase 7,500 shares of common stock [1] - The exercise price of the options is equal to the closing price of Autonomix's common stock on the grant date, and the options have a ten-year term, vesting in four equal annual installments [2]
Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)